Teneobio Announces the Presentation of Interim Phase I Data on TNB-383B (Anti-BCMAxCD3) at the 62nd Annual Meeting of the American Society of Hematology

Press/Media

Period19 Nov 2020

Media coverage

1

Media coverage

  • TitleTeneobio Announces the Presentation of Interim Phase I Data on TNB-383B (Anti-BCMAxCD3) at the 62nd Annual Meeting of the American Society of Hematology
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date19/11/20
    PersonsCesar Rodriguez
View all 1
View less